81_FR_7580 81 FR 7551 - National Institute on Drug Abuse; Notice of Closed Meetings

81 FR 7551 - National Institute on Drug Abuse; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 29 (February 12, 2016)

Page Range7551-7552
FR Document2016-02849

Federal Register, Volume 81 Issue 29 (Friday, February 12, 2016) 
[Federal Register Volume 81, Number 29 (Friday, February 12, 2016)]
[Notices]
[Pages 7551-7552]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-02849]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIH Pathway to Independence Award (K99/R00).
    Date: March 2, 2016.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Susan O. McGuire, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd., 
Room 4245, Rockville, MD 20852, 301-435-1426, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Identification of Genetic and Genomic Variants by 
Next-Gen Sequencing in Non-human Animal Models (U01).
    Date: March 2, 2016.
    Time: 12:00 p.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA Translational Avant-Garde Award for Development 
of Medication to Treat Substance Use Disorders (UG3/UH3).
    Date: March 4, 2016.
    Time: 8:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Phase II in person interview: Avenir Award Program 
for Research on Substance Abuse and HIV/AIDS (DP2).
    Date: March 8, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
4238, MSC 9550, Bethesda, MD 20892, 301-402-6020, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Phase II in person interview: Avenir Award Program 
for Genetics or Epigenetics of Substance Abuse (DP1).
    Date: March 10, 2016.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815. Contact Person: Hiromi Ono, Ph.D., Scientific 
Review Officer, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 4238, MSC 9550, Bethesda, MD 20892, 301-402-6020, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Exploratory Studies of Smoking Cessation 
Interventions for People with Schizophrenia (R21/R33).
    Date: March 11, 2016.
    Time: 1:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Jose F. Ruiz, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
Room 4228, MSC 9550, 6001 Executive Blvd., Bethesda, MD 20892-9550, 
(301) 451-3086, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Loan Repayment 2016.
    Date: March 15, 2016.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications and/or 
proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Policy and Review, National Institute on Drug Abuse, NIH, 
DHHS, Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 
20892-9550, (301) 435-1439, lf33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA Research ``Center of Excellence'' Grant Program 
(P50).
    Date: March 16, 2016.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, National Institute 
on Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 301-443-9511, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA Core Center of Excellence Grant Program (P30).
    Date: March 17, 2016.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Bethesda, MD 20852.
    Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review 
Officer, Office of Extramural Policy and Review, National

[[Page 7552]]

Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 
Executive Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 301-
443-9511, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)


    Dated: February 8, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
 [FR Doc. 2016-02849 Filed 2-11-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 29 / Friday, February 12, 2016 / Notices 7551 as amended. The contract proposals and Place: Hilton Washington/Rockville, 1750 Contact Person: Hiromi Ono, Ph.D., Scientific the discussions could disclose Rockville Pike, Rockville, MD 20852. Review Officer, Office of Extramural Affairs, confidential trade secrets or commercial Contact Person: Susan O. McGuire, Ph.D., National Institute on Drug Abuse, National Scientific Review Officer, Office of Institutes of Health, DHHS, 6001 Executive property such as patentable material, Extramural Affairs, National Institute on Boulevard, Room 4238, MSC 9550, Bethesda, and personal information concerning Drug Abuse, National Institutes of Health, MD 20892, 301–402–6020, individuals associated with the contract DHHS, 6001 Executive Blvd., Room 4245, hiromi.ono@nih.gov. proposals, the disclosure of which Rockville, MD 20852, 301–435–1426, Name of Committee: National Institute on would constitute a clearly unwarranted mcguireso@mail.nih.gov. Drug Abuse Special Emphasis Panel, invasion of personal privacy. Name of Committee: National Institute on Exploratory Studies of Smoking Cessation Name of Committee: National Institute on Drug Abuse Special Emphasis Panel, Interventions for People with Schizophrenia Drug Abuse Special Emphasis Panel; Identification of Genetic and Genomic (R21/R33). Standardized Rechargeable Electronic Variants by Next-Gen Sequencing in Non- Date: March 11, 2016. Nicotine Delivery System (8921). human Animal Models (U01). Time: 1:00 p.m. to 3:00 p.m. Date: March 15, 2016. Date: March 2, 2016. Agenda: To review and evaluate grant Time: 10:00 a.m. to 11:30 a.m. Time: 12:00 p.m. to 1:30 p.m. applications. Agenda: To review and evaluate contract Agenda: To review and evaluate grant Place: National Institutes of Health, proposals. applications. Neuroscience Center, 6001 Executive Place: National Institutes of Health, Place: National Institutes of Health, Boulevard, Rockville, MD 20852, (Telephone Neuroscience Center, 6001 Executive Neuroscience Center, 6001 Executive Conference Call). Boulevard, Rockville, MD 20852 (Telephone Boulevard, Rockville, MD 20852, (Telephone Contact Person: Jose F. Ruiz, Ph.D., Conference Call). Conference Call). Scientific Review Officer, Office of Contact Person: Lyle Furr, Scientific Contact Person: Jose F. Ruiz, Ph.D., Extramural Affairs, National Institute on Review Officer, Office of Extramural Affairs, Scientific Review Officer, Office of Drug Abuse, NIH, Room 4228, MSC 9550, National Institute on Drug Abuse, NIH, Extramural Affairs, National Institute on 6001 Executive Blvd., Bethesda, MD 20892– DHHS, Room 4227, MSC 9550, 6001 Drug Abuse, NIH, Room 4228, MSC 9550, 9550, (301) 451–3086, ruizjf@nida.nih.gov. Executive Boulevard, Bethesda, MD 20892– 6001 Executive Blvd., Bethesda, MD 20892– Name of Committee: National Institute on 9550, (301) 435–1439, lf33c.nih.gov. 9550, (301) 451–3086, ruizjf@nida.nih.gov. Drug Abuse Special Emphasis Panel, Loan (Catalogue of Federal Domestic Assistance Name of Committee: National Institute on Repayment 2016. Program No.: 93.279, Drug Abuse and Drug Abuse Special Emphasis Panel, NIDA Date: March 15, 2016. Addiction Research Programs, National Translational Avant-Garde Award for Time: 9:00 a.m. to 5:00 p.m. Institutes of Health, HHS) Development of Medication to Treat Agenda: To review and evaluate grant Substance Use Disorders (UG3/UH3). applications and/or proposals. Dated: February 8, 2016. Date: March 4, 2016. Place: National Institutes of Health, Natasha M. Copeland, Time: 8:30 a.m. to 12:30 p.m. Neuroscience Center, 6001 Executive Program Analyst, Office of Federal Advisory Agenda: To review and evaluate Boulevard, Rockville, MD 20852, (Virtual Committee Policy. cooperative agreement applications. Meeting). [FR Doc. 2016–02848 Filed 2–11–16; 8:45 am] Place: Bethesda North Marriott Hotel & Contact Person: Lyle Furr, Scientific BILLING CODE 4140–01–P Conference Center, 5701 Marinelli Road, Review Officer, Office of Extramural Policy Bethesda, MD 20852. and Review, National Institute on Drug Contact Person: Jose F. Ruiz, Ph.D., Abuse, NIH, DHHS, Room 4227, MSC 9550, Scientific Review Officer, Office of 6001 Executive Boulevard, Bethesda, MD DEPARTMENT OF HEALTH AND Extramural Affairs, National Institute on 20892–9550, (301) 435–1439, lf33c.nih.gov. HUMAN SERVICES Drug Abuse, NIH, Room 4228, MSC 9550, Name of Committee: National Institute on 6001 Executive Blvd., Bethesda, MD 20892– Drug Abuse Special Emphasis Panel, NIDA National Institutes of Health 9550, (301) 451–3086, ruizjf@nida.nih.gov. Research ‘‘Center of Excellence’’ Grant National Institute on Drug Abuse; Name of Committee: National Institute on Program (P50). Drug Abuse Special Emphasis Panel, Phase II Date: March 16, 2016. Notice of Closed Meetings in person interview: Avenir Award Program Time: 9:00 a.m. to 4:00 p.m. Pursuant to section 10(d) of the for Research on Substance Abuse and HIV/ Agenda: To review and evaluate grant Federal Advisory Committee Act, as AIDS (DP2). applications. amended (5 U.S.C. App), notice is Date: March 8, 2016. Place: Bethesda North Marriott Hotel & Time: 8:00 a.m. to 5:00 p.m. Conference Center, 5701 Marinelli Road, hereby given of the following meetings. Agenda: To review and evaluate grant Bethesda, MD 20852. The meetings will be closed to the applications. Contact Person: Jagadeesh S. Rao, Ph.D., public in accordance with the Place: Courtyard by Marriott, 5520 Scientific Review Officer, Office of provisions set forth in sections Wisconsin Avenue, Chevy Chase, MD 20815. Extramural Policy and Review, National 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Contact Person: Hiromi Ono, Ph.D., Institute on Drug Abuse, National Institutes as amended. The grant applications and Scientific Review Officer, Office of of Health, DHHS, 6001 Executive Boulevard, the discussions could disclose Extramural Affairs, National Institute on Room 4234, MSC 9550, Bethesda, MD 20892, confidential trade secrets or commercial Drug Abuse, National Institutes of Health, 301–443–9511, jrao@nida.nih.gov. property such as patentable material, DHHS, 6001 Executive Boulevard, Room Name of Committee: National Institute on and personal information concerning 4238, MSC 9550, Bethesda, MD 20892, 301– Drug Abuse Special Emphasis Panel, NIDA 402–6020, hiromi.ono@nih.gov. Core Center of Excellence Grant Program individuals associated with the grant applications, the disclosure of which Name of Committee: National Institute on (P30). asabaliauskas on DSK9F6TC42PROD with NOTICES2 Drug Abuse Special Emphasis Panel, Phase II Date: March 17, 2016. would constitute a clearly unwarranted in person interview: Avenir Award Program Time: 9:00 a.m. to 4:00 p.m. invasion of personal privacy. for Genetics or Epigenetics of Substance Agenda: To review and evaluate grant Name of Committee: National Institute on Abuse (DP1). applications. Drug Abuse Special Emphasis Panel, NIH Date: March 10, 2016. Place: Bethesda North Marriott Hotel & Pathway to Independence Award (K99/R00). Time: 8:00 a.m. to 5:00 p.m. Conference Center, 5701 Marinelli Road, Date: March 2, 2016. Agenda: To review and evaluate grant Bethesda, MD 20852. Time: 9:00 a.m. to 5:00 p.m. applications. Contact Person: Jagadeesh S. Rao, Ph.D., Agenda: To review and evaluate grant Place: Courtyard by Marriott, 5520 Scientific Review Officer, Office of applications. Wisconsin Avenue, Chevy Chase, MD 20815. Extramural Policy and Review, National VerDate Sep<11>2014 17:38 Feb 11, 2016 Jkt 238001 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\12FEN1.SGM 12FEN1

7552 Federal Register / Vol. 81, No. 29 / Friday, February 12, 2016 / Notices Institute on Drug Abuse, National Institutes Dated: February 8, 2016. the International Maritime Organization of Health, DHHS, 6001 Executive Boulevard, Melanie J. Gray, (IMO) has adopted a mandatory code, Room 4234, MSC 9550, Bethesda, MD 20892, Program Analyst, Office of Federal Advisory the International Code for Ships 301–443–9511, jrao@nida.nih.gov. Committee Policy. Operating in Polar Waters, commonly (Catalogue of Federal Domestic Assistance [FR Doc. 2016–02851 Filed 2–11–16; 8:45 am] referred to as the Polar Code. The Polar Program Nos.: 93.279, Drug Abuse and BILLING CODE 4140–01–P Code addresses safety and Addiction Research Programs, National environmental requirements for vessels, Institutes of Health, HHS) as well as the level of training required DEPARTMENT OF HOMELAND for deck officers, and is expected to Dated: February 8, 2016. come into force on January 1, 2017. SECURITY Natasha M. Copeland, In order to obtain input from U.S. Program Analyst, Office of Federal Advisory Coast Guard stakeholders and to facilitate the Committee Policy. development of the U.S. position at the [FR Doc. 2016–02849 Filed 2–11–16; 8:45 am] [Docket No. USCG–2016–0017] IMO on the training requirements BILLING CODE 4140–01–P needed to support the Polar Code, the Policy Letter: Guidance for Training of Merchant Marine Personnel Advisory Deck Officers on Vessels Subject to Committee (MERPAC) chartered a the International Code for Ships working group in 2013 to address DEPARTMENT OF HEALTH AND Operating in the Polar Waters HUMAN SERVICES mariner training in support of the polar AGENCY: Coast Guard, DHS. code. The working group developed a National Institutes of Health ACTION: Notice of availability. proposal that included the training competencies for U.S. mariners serving National Institute of General Medical SUMMARY: The Coast Guard announces on ships operating in polar waters. The Sciences; Notice of Closed Meeting the availability, in the docket, of a working group held multiple meetings policy letter which provides voluntary and provided recommendations on Pursuant to section 10(d) of the guidance for the training of deck officers minimum standards of competence, sea Federal Advisory Committee Act, as on vessels operating in polar waters. It service, and recency requirements for amended (5 U.S.C. App.), notice is recommends training measures that will polar training at the basic and advanced hereby given of the following meeting. achieve a higher level of safety for levels. The group also developed The meeting will be closed to the mariners working in this specialized recommendations on how existing public in accordance with the polar environment. It is applicable to mariners with experience operating in provisions set forth in sections SOLAS vessels operating outside the polar waters would be grandfathered 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., boundary line and subject to the under the new requirements. MERPAC as amended. The grant applications and International Code for Ships Operating adopted the working group’s the discussions could disclose in Polar Waters (Polar Code). The draft recommendations, which provided the confidential trade secrets or commercial policy letter and voluntary guidance basis of the U.S. position regarding the property such as patentable material, would not apply to vessels on voyages relevant amendments to the and personal information concerning that do not operate in areas subject to International Convention on Standards individuals associated with the grant the Polar Code. of Training, Certification and applications, the disclosure of which Watchkeeping for Seafarers (STCW DATES: This policy letter is effective on would constitute a clearly unwarranted Convention), 1978, as amended, and the February 12, 2016. invasion of personal privacy. Seafarers’ Training, Certification and FOR FURTHER INFORMATION CONTACT: If Watchkeeping Code (STCW Code). The Name of Committee: NIGMS Initial Review you have questions about this STCW Convention and Code provide Group; Training and Workforce Development document, contact Cathleen Mauro, the international standards for seafarers. Subcommittee—C. Marine Personnel Qualifications Through the work of the IMO’s Sub- Date: March 7, 2016. Division (CG–OES–1), U.S. Coast Guard; committee on Human Element, Training Time: 8:30 a.m. to 5:00 p.m. telephone 202–372–1449, or and Watchkeeping (HTW), amendments Agenda: To review and evaluate grant Cathleen.B.Mauro@uscg.mil. to the STCW Convention and Code were applications. developed to define the training SUPPLEMENTARY INFORMATION: Place: Ritz-Carlton Hotel, 1700 Tysons requirements needed to support the Boulevard, McLean, VA 22102. Viewing Materials in the Docket implementation of the Polar Code. Contact Person: Mona R. Trempe, Ph.D., The policy letter is available in the These amendments were approved by Scientific Review Officer, Office of Scientific Review, National Institute of General Medical docket and can be viewed by going to the Maritime Safety Committee on its Sciences, National Institutes of Health, 45 www.regulations.gov, inserting USCG– Ninety Fifth Session (MSC 95), and are Center Drive, Room 3AN12, Bethesda, MD 2016–0017 in the ‘‘Keyword’’ box, and expected to be adopted by the IMO in 20892, 301–594–3998, trempemo@ then clicking ‘‘Search.’’ July of 2016. The amendments are mail.nih.gov. expected to enter into force on January Background and Purpose (Catalogue of Federal Domestic Assistance 1, 2018. Program Nos. 93.375, Minority Biomedical Current shipping trends show an Cognizant that there is a gap between asabaliauskas on DSK9F6TC42PROD with NOTICES2 Research Support; 93.821, Cell Biology and increase in the number of vessels the time the Polar Code enters into force Biophysics Research; 93.859, Pharmacology, regularly transiting remote polar areas. on January 1, 2017 and the adoption of Physiology, and Biological Chemistry Vessels in polar waters experience the amendments to the STCW Research; 93.862, Genetics and unpredictable and poor weather Convention by IMO in July of 2016, the Developmental Biology Research; 93.88, conditions, degraded navigation tools, Coast Guard has developed a policy Minority Access to Research Careers; 93.96, threats to operating equipment and letter that recommends training Special Minority Initiatives; 93.859, increased stability concerns. In response guidelines for deck officers on vessels Biomedical Research and Research Training, to the challenges faced by these vessels operating in polar waters. The Coast National Institutes of Health, HHS) and the concern for their safe operation, Guard is providing this guidance to VerDate Sep<11>2014 17:38 Feb 11, 2016 Jkt 238001 PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 E:\FR\FM\12FEN1.SGM 12FEN1


Document Created: 2016-02-12 01:23:45
Document Modified: 2016-02-12 01:23:45
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesMarch 2, 2016.
FR Citation81 FR 7551 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR